23
Participants
Start Date
February 1, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
February 26, 2013
p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine
p.DOM-WT1-37: 1mg/dose/vaccine p.DOM-WT1-126: 1mg/dose/vaccine The DNA vaccine will be administered 6 times at 4 weekly intervals. Responders (Immunological but without molecular progression) may continue vaccination 3 monthly to maximum of 24 months. The vaccines will be injected intramuscularly (im) followed by electroporation (EP) into separate locations.
Royal Devon and Exeter NHS Foundation Trust, Exeter
Imperial College NHS Trust, London
Southampton University Hospitals NHS Trust, Southampton
Collaborators (1)
Imperial College Healthcare NHS Trust
OTHER
Royal Devon and Exeter NHS Foundation Trust
OTHER
Inovio Pharmaceuticals
INDUSTRY
Efficacy and Mechanism Evaluation (EME) Programme
OTHER
Leukemia Research Fund
OTHER
University Hospital Southampton NHS Foundation Trust
OTHER